Evidence map›Paper›PMID 42646133›Full record

ArticleJournal of fungi (Basel, Switzerland)2026

Fluconazole Disk Diffusion on CHROMagar Candida Plus for Differentiation Between

Sarah Israel, Jonathan Lellouche, Loujin Ardda, Ariel Israel, Sharon Amit, Ronen Ben-Ami, Itzhack Polacheck, Jacob Moran-Gilad, Maya Korem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sarah IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9101002, Israel.ORCID 0000-0001-5646-0071
Jonathan LelloucheClinical Laboratories Department, Sanz Medical Center, Netanya 4244916, Israel.ORCID 0000-0002-0564-4409
Loujin ArddaFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9101002, Israel.
Ariel IsraelLeumit Research Institute, Leumit Health Services, Tel Aviv 6473817, Israel.ORCID 0000-0003-4389-8896
Sharon AmitClinical Microbiology Laboratory, The Chaim Sheba Medical Center, Ramat Gan 5266202, Israel.
Ronen Ben-AmiGray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0003-0628-0798
Itzhack PolacheckFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9101002, Israel.ORCID 0000-0002-4325-5260
Jacob Moran-GiladFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9101002, Israel.
Maya KoremFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9101002, Israel.ORCID 0000-0003-3276-0963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluated the utility of fluconazole disk diffusion on CHROMagar Candida Plus for differentiating

methodsIn this in vitro study, clinical isolates of both

resultsThis study demonstrates high categorical agreement between disk diffusion on CHROMagar Candida Plus and broth microdilution for both species. An optimal cut-off zone diameter of 10 mm was identified on CHROMagar Candida Plus with 50 µg fluconazole, providing 91% sensitivity and 90% specificity for differentiating the two species. Notably, at 24 h, 83 out of 88 (94.3%)

conclusionsFluconazole disk diffusion on CHROMagar Candida Plus, supplemented by reverse-side colony coloration, offers a practical, low-cost adjunctive strategy to aid in the differentiation of

Indexed as

antifungal susceptibility testingCandida parapsilosisCandidozyma aurisCHROMagar Candida Plusfluconazole disk diffusionphenotypic identification

Identifiers

PMID42646133
PMCPMC13514406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.